Persistent Helicobacter pylori Infection: An Insight to the Limitations of Current Clinical Practice
Open Access
- 25 December 2020
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 12 (12)
Abstract
The discovery of the pathological role of Helicobacter pylori in various disease states, such as peptic ulcer disease (PUD) and Mucosa Associated Lymphoid Tissue (MALT) lymphoma, was ground-breaking in the field of gastroenterology. Given the potentially dire clinical implications of chronic H. pylori infection, it is important to achieve complete eradication. More importantly, the rising prevalence of H. pylori antimicrobial resistance, similar to other pathogens world-wide, is of particular concern. Despite evidence supporting the growing threat of antimicrobial resistance, clinically, it is also important to survey just how much of the failed treatment is truly a reflection of resistance versus poor treatment adherence. In this report, we detail the case of a 64-year-old female who was previously given six treatment courses for persistent H. pylori infection. Successful eradication was achieved with rifabutin triple therapy consisting of high-dose amoxicillin and strict adherence monitoring by a clinical pharmacist. This case highlights the importance of patient education, medication reconciliation, and close monitoring to ensure successful treatment of persistent H. pylori infection.Keywords
This publication has 12 references indexed in Scilit:
- Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization RegionsGastroenterology, 2018
- Inappropriate treatment in Helicobacter pylori eradication failure: a retrospective studyScandinavian Journal of Gastroenterology, 2017
- Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-AnalysisGastroenterology, 2017
- ACG Clinical Guideline: Treatment of Helicobacter pylori InfectionAmerican Journal of Gastroenterology, 2017
- Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus ReportGut, 2016
- Helicobacter pylori infection: An overview of bacterial virulence factors and pathogenesisBiomedical Journal, 2016
- Review: Improving compliance with Helicobacter pylori eradication therapy: when and how?Therapeutic Advances in Gastroenterology, 2009
- Management ofHelicobacter pylorieradication – the influence of structured counselling and follow‐upBritish Journal of Clinical Pharmacology, 2002
- A Randomized Controlled Trial of an Enhanced Patient Compliance Program for Helicobacter pylori TherapyArchives of internal medicine (1960), 1999
- Factors influencing the eradication of Helicobacter pylori with triple therapyGastroenterology, 1992